Pulmonary and Critical Care Medicine 2027

Continuing Education

April 26 - 30, 2027

This course is preparing to open for registration. Please check back soon.

Pulmonary and Critical Care Medicine 2027 offers a comprehensive update on state-of-the-art evaluation, diagnosis, treatment, and procedures for patients with common, rare, and challenging pulmonary conditions and for patients requiring critical care.

Live Online

This program uses state-of-the-art streaming technology to present sessions online in real time. Participants can attend from any location, and can interact with faculty via live chat.

Additionally, all sessions will be recorded and made available to participants for online viewing for 120 days after the end of the course.

All live streaming and recorded sessions are eligible for AMA PRA Category 1 Credits™ and other relevant credits. (Note: Evaluations must be completed within 60 days of the conclusion of the course to receive CME credit.)

$1,345 Save with early registration

Save $100. The tuition listed above is for physicians; see the course fee table for pricing for other health professionals. To ensure your participation at the lowest possible cost, early registration is strongly recommended.

Fee increases to $1,445 after March 31, 2027

Continuing Education

Earn up to:

» 49.25 AMA PRA Category 1 Credits™

» 49.25 ABIM MOC points

» 49.25 European CME credits (ECMEC^®)

» Commensurate credits through the Royal College of Physicians and Surgeons of Canada

5 Days

This intensive course, which is among the highest-rated Harvard Medical School CME courses, presents the most up-to-date, evidence-based approaches to pulmonary conditions and patients in need of critical care.

Overview

Comprehensive Updates for State-of-the-Art Care: Evaluation, Diagnosis, Treatment, Procedures, and Challenging Cases

Pulmonary and Critical Care Medicine is a live online course, using live streaming, electronic Q&A, and other remote learning technologies.

This comprehensive course provides education and updates to optimize your care of patients with pulmonary conditions and patients requiring critical care. Physicians, NPs, and PAs can rely on this program to enhance their practice and advance their knowledge with evidence-based strategies for evaluation, diagnosis, treatment, and procedures.

All sessions are led by master clinicians who deliver information in inspiring and entertaining ways and provide specific recommendations to incorporate the latest updates into your practice. This year’s program covers:

Breaking news updates in pulmonary and critical care medicine
The most current guidelines for treating sepsis
Evidence-based treatment of ARDS
Interventional pulmonology: diagnostic procedures, therapeutic interventions, and as an alternative to surgery
High-flow oxygen therapy for respiratory failure
Updates on biologics in asthma and other lung disease
Diagnosis and management of bleeding diatheses in the ICU
New concepts in the use of vasopressors in septic shock
New drugs and combinations in pulmonary hypertension
New evidence on sedation, analgesia, and early mobility in the ICU
Point-of-care pulmonary ultrasound in the intensive care unit
Lung microbiome: emerging implications for lung health
Emerging evidence for targeted temperature management
Steroid-sparing agents for interstitial lung disease
Pulmonary embolus: the latest treatment strategies
Guidance to conduct end-of-life discussions
Updates in pulmonary pathology
New treatment options in cystic fibrosis
Handling neurologic and surgical emergencies in the medical ICU

A Practical, Comprehensive Update for Busy Clinicians
This program delivers comprehensive updates to improve evaluation, diagnosis, and management of the broad array of pulmonary and critical care conditions:

IPF
Non-IPF ILD
ARDS
Sarcoidosis
Lung transplantation
Bronchiectasis
Cystic fibrosis
Lung nodules
Lung cancer
Sepsis
Pleural disease
Pneumonia
Tuberculosis
Thromboembolism
COPD
Asthma
GERD
Neurologic issues in the ICU
Sleep-disordered breathing
Surgical emergencies
Acute pancreatitis
Atypical mycobacterial disease
Pulmonary hypertension
Post-cardiac arrest care
Hypersensitivity pneumonitis
Ventilator management

Participants also have access to expanded question and answer sessions with faculty throughout the program, which promotes discussion of the complexity of real-world care.

On the afternoon of Friday, April 30, participants can attend a special half-day program at no additional cost: Sleep Medicine. More information below.

In addition to being live streamed, all sessions will be recorded and placed in the online course library, enabling registrants to view them at their convenience. Recordings will be available for viewing for 120 days after the conclusion of the course. All live streaming and recorded sessions are eligible for AMA PRA Category 1 Credits™ and other relevant credits. (Note: Evaluations must be completed within 60 days of the conclusion of the course to receive CME credit.)

Developed and Offered By:

Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by Massachusetts General Hospital.

Schedule

This program is among the highest-rated Harvard Medical School CME courses.
All schedule times are in Eastern Time.
Please note that program changes/substitutions may be made without notice.

View and Print Full Schedule

Monday, April 26, 2027

Day 1

Monday, April 26, 2027

Tuesday, April 27, 2027

Day 2

Tuesday, April 27, 2027

Wednesday, April 28, 2027

Day 3

Wednesday, April 28, 2027

Thursday, April 29, 2027

Day 4

Thursday, April 29, 2027

Friday, April 30, 2027

Day 5

Friday, April 30, 2027

Optimized for Distance Learning

In addition to being live streamed, all sessions and Q & A discussions will be recorded and made available to participants for online viewing for 120 days after the end of the course. This on-demand archive will permit those in different time zones or who have scheduling conflicts to view all sessions that are important to them. In addition, participants can review sessions to reinforce key learning points.

Q&A with Faculty

The 2027 program will be highly interactive, providing opportunities throughout the program to pose questions online to nationally and internationally recognized leaders in their respective areas of pulmonary and critical care medicine.

Special Half-Day Program

Sleep Medicine

April 30, 2027, 1:00-5:40 pm
(No additional fees apply)

This program provides the opportunity to learn about recent advances in Sleep Medicine and how they impact clinical practice. Highlights of this practical, interactive educational experience include:

Updates for diagnosis and management of sleep-disordered breathing
State-of-the-art management algorithms
New technologies vs. the “gold standard” polysomnogram
Reimbursement and telemedicine
Improved adherence to therapy

Participants will leave with specific recommendations to improve the clinical care of patients with sleep disorders.

Learning Objectives

Upon completion of this course, participants will be able to:

Evaluate the pathophysiology of lung disease and critical illness, including key pathologic and radiologic features
Apply evidence from recent literature to clinical case management
Apply new clinical practice guidelines to improve patient outcomes
Utilize diagnostic and therapeutic tools offered by specialists outside of pulmonary and critical care medicine to optimally care for complicated patients
Review the latest evidence and best clinical practices for fluid resuscitation and vasopressor use

Faculty

Course Directors

Angela Frank

MD, MPH

Instructor in Medicine, Harvard Medical School
Physician, Massachusetts General Hospital

Kathryn A. Hibbert

Assistant Professor of Medicine, Harvard Medical School
Director, Medical ICU, Massachusetts General Hospital

Miranda Theodore

Instructor in Medicine, Harvard Medical School

Eric Schmidt

Associate Professor of Medicine, Harvard Medical School
Chief and Andrew M. Tager, MD Endowed Chair, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital

Harvard Medical School Faculty

2027 faculty list coming soon.

Guest Faculty

2027 faculty list coming soon.

Sign up to receive 2027 course announcements and details

First Name

Last Name

Country of Residence

Job Title

Employer/Institution

Industry Affiliation

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Course Fees

Registration Details

Registrations for Harvard Medical School CME programs are made via our secure online registration system. At the end of the registration process, a $10 non-refundable processing fee will be added to your registration.

Upon receipt of your paid registration, an email confirmation will be sent to you. Be sure to include an email address that you check frequently. Your email address is used for critical information, including registration confirmation, evaluation, and certificate.

Please review the cancellation policy.

Early Registration Deadline: March 31, 2027

Role	Course Fee	Early Registration Course Fee
Physician (MD/DO)	$1,445	$1,345
Nurse (RN/APRN)	$1,345	$1,245
PA	$1,345	$1,245
Resident / Fellow	$1,345	$1,245
Allied Health Professional / Other	$1,345	$1,245

All registrants of Pulmonary and Critical Care Medicine 2027 will receive an electronic syllabus.

All sessions will be recorded as they are live streamed and placed in the online course video library, so that registrants can review them at their convenience. The video library will be available for 120 days after the conclusion of the course.

Accreditation

In support of improving patient care, Harvard Medical School is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Live/Live Online Courses: To receive CME/CE credit, learners are required to complete the course evaluation. Once the evaluation is complete, you will be able to claim your credit and download your certificate. All evaluations and credit claims must be completed within 60 days of the course end date.

Online Courses: To receive CME/CE credit, learners must pass the course post-test and complete the course evaluation in order to claim credit before the final day of the accreditation period. Learners have access to the course for 60 days after the accreditation period has expired.

Physicians

Badge for Jointly Accredited Provider with Commendation Interprofessional Continuing Education

The Harvard Medical School designates this live activity for a maximum of 49.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 49.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nurse Practitioners and Registered Nurses

For the purpose of recertification, the American Academy of Nurse Practitioners Certification Board and American Nurses Credentialing Center accept AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education). We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.

Physician Assistants

The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.

Royal College of Physicians and Surgeons of Canada (RCPSC)

The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.

Union of European Medical Specialists

The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialists (UEMS). Additional information regarding this agreement may be found on the Union of European Medical Specialists website.

Competencies

ABMS/ACGME Competencies

This course is designed to meet the following American Board of Medical Specialties (ABMS) / Accreditation Council for Graduate Medical Educational (ACGME) competencies:

Patient Care and Procedural Skills
Professionalism
Practice-Based Learning and Improvement
Medical Knowledge
Systems-Based Practice

IOM Competencies

This course is designed to meet the following Institute of Medicine Core Competencies:

Employ Evidence-Based Practice
Work in Interdisciplinary Teams
Provide Patient-Centered Care

Disclaimer & Disclosure

Disclaimer Policy

CME activities accredited by Harvard Medical School are offered solely for educational purposes and do not constitute any form of certification of competency. Practitioners should always consult additional sources of information and exercise their best professional judgment before making clinical decisions of any kind.

Note: AMA PRA Category 1 Credit™ is calculated based on submission of a preliminary agenda and may be subject to change.

Disclosure

In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education (ACCME), course planners, speakers, and content reviewers have been asked to disclose any relationships they have to companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss.

Registration for courses managed by Harvard Medical School can only be completed through Harvard Medical School’s official registration portal: cmeregistration.hms.harvard.edu. Attendee registrations made through any other sites cannot be honored and will not be refunded. Please report any unauthorized websites or solicitations for registrations.

In order to comply with applicable U.S. export control and sanctions regulations, Harvard Medical School prohibits access to and use of Harvard Medical School educational offerings, programs and resources to individuals from certain sanctioned regions or who are otherwise subject to U.S. government sanctions, unless appropriate authorization is in place.

Program Topics

Clinical Practice

Pulmonary and Critical Care Medicine 2027

On This Page

Overview

Comprehensive Updates for State-of-the-Art Care: Evaluation, Diagnosis, Treatment, Procedures, and Challenging Cases

Developed and Offered By:

Who Should Participate

Schedule

Monday, April 26, 2027

Monday Morning Sessions

Welcome

Breaking News in Pulmonary Medicine

Cystic Fibrosis: Understanding CFTR and New Treatment

Beyond Cystic Fibrosis: Diagnosis and Management of Non-CF Bronchiectasis

Lung Transplantation 2027: Referral, Patient Selection, Lung Allocation, and COVID

Exercise and Cardiopulmonary Disorders: Indications and Interpretation

Q&A with Speakers

Monday Afternoon Sessions

Pulmonary Pathology: Interstitial Lung Disease

Looking Deeper: Patterns and Insights from Chest Radiology

Evolving Concepts in the Diagnosis and Management of Connective Tissue Disease-Associated ILD

Hypersensitivity Pneumonitis: Pigeons, Farmers, and Hot Tubs, Oh My!

Treatment Challenges of Pulmonary Sarcoidosis

Diagnosis and Management of IPF: When, Why, and How to Use the Newest Drugs

Q&A with Speakers

Tuesday, April 27, 2027

Tuesday Morning Sessions

Sedation, Analgesia, and Early Mobility: The State of the Art in 2027

Newer, Better, Faster, Stronger: Noninvasive Respiratory Support for Acute Respiratory Failure

ECMO Support for Respiratory Failure

ARDS: State-of-the-Art Strategies to Protect the Lung

After the ICU: Post-ICU Care Syndrome and Recovery

Q&A with Speakers

Tuesday Afternoon Sessions

From Ancient Egypt to Balanced Crystalloids: Medicine's Attempts to Manage Sepsis

Fluid Responsiveness

Vasopressors in Septic Shock: Old Friends and New

Approach to Empiric Antibiotics in the ICU

Approach to the Immunocompromised Critically Ill Patient

Renal Replacement Therapy in the ICU: What and When to Start (or Not)

Q&A with Speakers

Wednesday, April 28, 2027

Wednesday Morning Sessions

Common Neurologic Issues in the ICU

TTM and Neuroprognostication After Cardiac Arrest

Surgical Emergencies in the Medical ICU

Updates in Management of Acute Pancreatitis

Advanced Cardiac Support in the ICU

Q&A with Speakers

Wednesday Afternoon Sessions

Breaking Updates in Critical Care

Management of the Acutely Hemorrhaging Patient

Point-of-Care Ultrasound in the Intensive Care Unit

Pneumonia (Community and Hospital Acquired): Using the Newest Guidelines to Provide Evidence-Based Care

Prognosis and Uncertainty in the ICU

Liver Failure in the Medical ICU: New Approaches and How to Improve Outcomes

Q&A with Speakers

Thursday, April 29, 2027

Thursday Morning Sessions

Pleural Disease: 2027 Updates

Interventional Pulmonology in 2027

Interventional Bronchoscopy in COPD: Valves, Coils, and Beyond

Treatment of Non-Small Cell Lung Cancer: Traditional Chemotherapy, Targeted Therapy, and Immunotherapies

COPD in 2027

Q&A with Speakers

Thursday Afternoon Sessions

Aspergillus Lung Disease

Asthma

New Therapeutics in Lung Disease: The Age of Immunotherapy

A Strategic Approach to the Management of Pulmonary Nodules

Tuberculosis in 2027

Nontuberculous Mycobacterial Disease: Navigating the Labyrinth

Q&A with Speakers

Friday, April 30, 2027

Friday Morning Sessions

Thrombotic Mechanisms and Antithrombotic Agents: How Do the New Oral Agents Fit in 2027?

Pulmonary Embolism: An Update

Pulmonary Hypertension: Categorization and Evaluation

Pulmonary Hypertension: Management

Vasculitis and ANCA

Q & A with Speakers